Literature DB >> 21791686

Clinical inertia and uncertainty in medicine.

Arun V Mohan, Lawrence S Phillips.   

Abstract

Mesh：

Year:  2011        PMID： 21791686     DOI： 10.1001/jama.2011.1044

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  9 in total

Review 1.  Glycemic control in type 2 diabetes: from medication nonadherence to residual vascular risk.

Authors:  Dario Giugliano; Maria Ida Maiorino; Giuseppe Bellastella; Katherine Esposito
Journal:  Endocrine       Date:  2018-01-10       Impact factor: 3.633

2.  Clinical Characteristics and Unmet Need Among Patients with Atherosclerotic Cardiovascular Disease Stratified by Statin Use.

Authors:  Qing Huang; Michael Grabner; Robert J Sanchez; Vincent J Willey; Mark J Cziraky; Swetha R Palli; Thomas P Power
Journal:  Am Health Drug Benefits       Date:  2016-11

3.  Overcoming Therapeutic Inertia in Multiple Sclerosis Care: A Pilot Randomized Trial Applying the Traffic Light System in Medical Education.

Authors:  Gustavo Saposnik; Jorge Maurino; Angel P Sempere; Maria A Terzaghi; Christian C Ruff; Muhammad Mamdani; Philippe N Tobler; Xavier Montalban
Journal:  Front Neurol       Date:  2017-08-21       Impact factor: 4.003

4.  Decision-making in Multiple Sclerosis: The Role of Aversion to Ambiguity for Therapeutic Inertia among Neurologists (DIScUTIR MS).

Authors:  Gustavo Saposnik; Angel P Sempere; Daniel Prefasi; Daniel Selchen; Christian C Ruff; Jorge Maurino; Philippe N Tobler
Journal:  Front Neurol       Date:  2017-03-01       Impact factor: 4.003

5.  Therapeutic Inertia in Multiple Sclerosis Care: A Study of Canadian Neurologists.

Authors:  Gustavo Saposnik; Xavier Montalban; Daniel Selchen; Maria A Terzaghi; Fabien Bakdache; Alonso Montoya; Manuel Fruns; Fernando Caceres; Jiwon Oh
Journal:  Front Neurol       Date:  2018-09-24       Impact factor: 4.003

6.  Effect of an Educational Intervention on Therapeutic Inertia in Neurologists With Expertise in Multiple Sclerosis: A Randomized Clinical Trial.

Authors:  Gustavo Saposnik; Marcus Grueschow; Jiwon Oh; Maria A Terzaghi; Pawel Kostyrko; Shruthi Vaidyanathan; Rosane Nisenbaum; Christian C Ruff; Philippe N Tobler
Journal:  JAMA Netw Open       Date:  2020-12-01

7.  Decision making under uncertainty, therapeutic inertia, and physicians' risk preferences in the management of multiple sclerosis (DIScUTIR MS).

Authors:  Gustavo Saposnik; Angel Perez Sempere; Roula Raptis; Daniel Prefasi; Daniel Selchen; Jorge Maurino
Journal:  BMC Neurol       Date:  2016-05-04       Impact factor: 2.474

8.  Therapeutic Inertia in the New Landscape of Multiple Sclerosis Care.

Authors:  Gustavo Saposnik; Xavier Montalban
Journal:  Front Neurol       Date:  2018-03-20       Impact factor: 4.003

9.  The Role of Prescribing Generic (Non-proprietary) Drugs in the Prevalence of Therapeutic Inertia in Multiple Sclerosis Care.

Authors:  Gustavo Saposnik; Muhammad Mamdani; Maria Terzaghi; Maria Laura Saladino; Berenice Silva; Philippe N Tobler; Fernando Caceres
Journal:  Front Neurol       Date:  2018-10-12       Impact factor: 4.003
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.